相关实验视频
Updated: May 12, 2025

06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
23.2K
上腺切除术后早期再入院,因为色细胞瘤. 一个回顾性研究研究
Tamer A A M Habeeb1, Abd Al-Kareem Elias2, Abdelmonem A M Adam2
1Department of General Surgery, Faculty of Medicine, Zagazig University, Zagazig, Egypt. tameralnaimy@hotmail.com.
Langenbeck's archives of surgery
|May 8, 2025
概括
染细胞瘤 (PHEO) 手术后的早期入院是常见的. 较低的BMI,较小的瘤和较低的ASA得分降低了再入院风险,而恶性瘤,开放性手术和手术后并发症增加了风险.
科学领域:
- 内分泌学 在内分泌学.
- 手术瘤学手术瘤学
- 临床研究 临床研究
背景情况:
- 染细胞瘤 (PHEO) 手术或上腺切除术与高率的早期住院再入院 (ER) 相关.
- 了解导致ER的因素对于改善患者的治疗结果和减少医疗保健负担至关重要.
研究的目的:
- 为了评估PHEO的上腺切除术后30天内ER的发生率.
- 在接受PHEO手术的患者中确定与ER相关的独立风险因素.
主要方法:
- 对346名单边PHEO患者的成年患者进行了回顾性分析,这些患者接受了上腺切除术.
- 患者被分为ER (n=49) 和没有ER (n=297) 组.
- 使用后勤回归分析来确定ER的风险因素.
主要成果:
- 最常见的ER原因是手术后的低血压 (42.9%) 和大 (24.5%).
- 对ER的风险降低与较低的体重指数,瘤大小<5厘米和较低的美国麻醉学会 (ASA) 评分有关.
- 增加ER风险与恶性瘤,开放式手术方法和手术后并发症有关.
结论:
- 手术后的低血压和大肠是PHEO上腺切除术后ER的主要驱动因素.
- 减少ER的预测因素包括低BMI,小瘤大小和低ASA分类.
- 恶性病,开放式手术技术和手术内并发症独立地增加了ER的风险.
相关概念视频
Adrenal Gland Disorders
1.2K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.2K
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
506
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
506
Adrenergic Agonists: Therapeutic Uses
681
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
681

